High-resolution chromosomal microarray analysis of early-stage human embryonic stem cells reveals an association between X chromosome instability and skewed X inactivation by unknown
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X chromosome inactivation (XCI) is a dosage compensation mechanism that silences the majority of genes on
one X chromosome in each female cell via a random process. Skewed XCI is relevant to many diseases, but the
mechanism leading to it remains unclear. Human embryonic stem cells (hESCs) derived from the inner cell mass
(ICM) of blastocyst-stage embryos have provided an excellent model system for understanding XCI initiation and
maintenance. Here, we derived hESC lines with random or skewed XCI patterns from poor-quality embryos and
investigated the genome-wide copy number variation (CNV) and loss of heterozygosity (LOH) patterns at the early
passages of these two groups of hESC lines. It was found that the average size of CNVs on the X chromosomes in
the skewed group is twice as much as that in the random group. Moreover, the LOH regions of the skewed group
covered the gene locus of either XIST or XACT, which are master long non-coding RNA (lncRNA) effectors of XCI in
human pluripotent stem cells. In conclusion, our work has established an experimentally tractable hESC model for
study of skewed XCI and revealed an association between X chromosome instability and skewed XCI.
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X chromosome inactivation (XCI) is the mechanism by
which dosage compensation of the sex chromosome is
achieved in females. XCI evolved into a random process
in cells from the embryo proper, with either the maternal
or paternal X chromosome being inactivated in a random
fashion [1]. However, skewed XCI, that is, with only ma-
ternal or only paternal X chromosome being inactivated
in the whole individual, has been linked to the develop-
ment of various diseases, including premature ovarian fail-
ure, spontaneous miscarriage and some cancers and may
induce or deteriorate X-linked genetic diseases, including
Rett syndrome, Duchenne muscular dystrophy and fragile* Correspondence: xiaofangsun@hotmail.com
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unless otherwise stated.X syndrome, via expressing the recessive mutant allele
solely [2-7].
The initiation and maintenance of XCI are essentially
dependent on long non-coding RNAs (lncRNAs). The
most important effector is XIST (X-inactive specific tran-
script), whose gene is mapped on Xq13 (73,040,486-
73,072,588 bp) and composes of the X inactivation center
(XIC) along with another two RNA genes, JPX and FTX.
In female cells, the XIST gene is active on only one of X
chromosomes, expressing a large (17 kb), non-coding
transcript that coats and silences the chromosome in cis
[8]. In human preimplantation embryos, XIST is expressed
from both paternal and maternal X chromosomes but
does not lead to chromosome-wide silencing, indicating a
role in XCI initiation [9]. Recently, XACT (X-active coat-
ing transcript), whose gene is located on chromosome
Xq23 (112,983,323-113,235,148 bp) in an unusually large
intergenic domain of 1.7 Mb (only 1% of intergenic re-
gions in humans are >1.5 Mb), has been identified as the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ally in human pluripotent stem cells, indicating a role in
the specific kinetics of XCI in humans [8]. However, epi-
genetic mechanism that is causing or associated with
skewed XCI remains unclear.
Previous studies have characterized XCI status in hu-
man embryonic stem cells (hESCs) found it an excellent
model system to investigate the association between epi-
genetic alternations and XCI [10,11]. It has been reported
that XCI variations already exist in the early passages (pas-
sage 5 to 15) of hESCs, which may be a consequence of
in vitro culture selection during the derivation process
[12,13]. Single nucleotide polymorphism (SNP) analysis
indicated hESCs at early passages had relative genome sta-
bility; however, the instability becomes stronger with the
increase in passage number (passage >20) [14]. Therefore,
it would be better to evaluate the XCI status of hESCs at
early stages that have been minimally exposed to culture
effects.
Chromosomal microarray analysis (CMA) has emerged
as a new high-throughput technique to investigate the
genome-wide CNV and loss of heterozygosity (LOH) pat-
terns in hESCs. CNV is a major form of genome structural
variation that relative large regions (1 kb to several Mbs
in size) of certain chromosome have been deleted (loss) or
duplicated (gain). LOH is another major form of variations
that a gross region of the chromosome loses one parental
copy due to deletion or uniparental disomy. Thus, an in-
crease of CNV and LOH represents higher genome instabil-
ity. In previous studies, CMA of human pluripotent stem
cell lines have identified a CN gain of chromosome 20q11.21
shared in >20% of hESC lines and 18% of human induced
pluripotent stem cells, and the cells containing this ampli-
con have a higher population doubling rate, which is attrib-
utable to enhanced resistance to apoptosis [15-18]. BCL2L1,
a gene within this common amplicon, is later demonstrated
to be a major effector for driving culture adaptation of
hESCs [19]. Hence, CMA is a powerful tool to identify
genome loci associated to specific traits in hESCs.
In this study, we established 9 hESC lines from poor-
quality embryos to generate an experimentally tractable
human cellular model to investigate random versus skewed
XCI patterns. We classified 3 cell lines with random XCI
pattern and another 3 lines with skewed XCI pattern, and
compared their genome-wide CNV and LOH patterns via
CMA at early passages. Our data showed that CNVs on
the X chromosomes of the skewed group were twice more
than those of the random group. Moreover, the LOH
regions of the skewed group covered either the XIST
or the XACT locus. In conclusion, our work indicated an
association between increased X chromosome instability
and skewed XCI, and we speculated that LOH in either
the XIST or the XACT locus is a factor that influences
XCI patterns.Materials and methods
Deviation and characterization of hESC lines
This study had obtained the approval of the Ethics
Committee of The Third Affiliated Hospital of Guangzhou
Medical University. Patients were enrolled at the Third
Affiliated Hospital of Guangzhou Medical University
(Guangzhou, China) and had signed their names by Chinese
on written informed consent, agreeing that their aban-
doned embryos to be used for stem cell research pur-
pose. Poor-quality embryos were cultured in a modified
medium for 7 days, as described Fan et al. [20]. Only
grade 3 and grade 4 embryos were selected. The inner cell
mass (ICM) was isolated by mechanical means. All ICMs
were plated on mitomycin C-treated murine embryonic
fibroblast feeder layers for further culture. After 8–9 days
of culture, the colonies derived from the ICM were mech-
anically dispersed into 2–3 small clumps using a micro-
pipette. The ICM clumps were then transferred to a fresh
feeder layer. These cells were again mechanically dissoci-
ated during the initial 5 passages. The cells were routinely
passed every 4–5 days, and the medium was changed
every day. All the cells lines were evaluated for pluripotent
potential via in vitro and in vivo differentiation analyses,
as previously described by Liu and Sun [21]. All the cell
lines were passaged until P8 to P10 and harvested for
CMA.
DNA extraction and purification
Whole-genome DNA was extracted with the QiAamp
DNA Blood Mini Kit according to the manufacturer’s in-
structions (QIAGEN, Germany). DNA was purified with
ammonium acetate and ethanol. The concentration and
quality of the DNA samples were determined using a spec-
trophotometer (Nanodrop 2000, Thermo Scientific, USA)
and 1% agarose gel electrophoresis with λDNA as a con-
trol. A 200 ng sample of DNA was used for the bisulfite
reaction. Complete bisulfite conversion and the cleanup of
converted DNA was processed using the EpiTect Bisulfite
Kit (QIAGEN).
HUMARA gene heterozygosity and XCI assays
The human androgen-receptor (HUMARA) gene has a
highly polymorphic trinucleotide short tandem repeat
(STR) in the first exon, which can be utilized to differentiate
heterozygous X chromosomes by AFLP assays. The CpG
sites (including HpaII and HhaI sites) <100 bp away from
this STR are methylated on inactive X chromosomes but
remain unmethylated on active X chromosomes, which
can be utilized to detect the XCI pattern by methylation-
specific PCR assays. The PCR primer sets for analysis of
HUMARA gene heterozygosity and methylation pattern
are designed based on Liu and Sun [21], whose se-
quences can be found in Additional file 1: Table S1. The
method is more illustrated in Additional file 2: Figure S1.
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as follows: 10 ×RT-PCR Buffer, 1.5 μl; 25 mM MgCl2, 0.9 μl;
dNTP Mix (10 mM), 1.5 μl; Primer-M/U (10 pmol/μl) F/R,
0.2 μl; Taq Golden Enzyme, 0.1 μl; bisulfite-treated DNA,
1.5 μl; RNase-free water, 9.1 μl. The reaction was per-
formed under the following conditions: 95°C for 12 min,
followed by 40 cycles of 30 s at 94°C, 30 s at 55°C, 30 s at
72°C and extension for 7 min at 72°C. A Genetic analyzer
3500 was used for fragment analysis, and the data were then
analyzed by Genemapper software (Applied Biosystems,
CA, USA).
Chromosomal microarray analysis
We used high-resolution genotyping microarray Affymetrix
CytoScan 750 K Array (Affymetrix, Santa Clara, CA, USA)
according to the manufacturer’s instructions. 250 ng unde-
graded DNA of each sample was used for the array. The
expected size of the PCR products was 150–2000 bp, with
a concentration of over 300 ng/μl and OD260/280 and
OD260/230 values of 1.8-2.0 and 2.0-2.3, respectively. The
size of fragmentation was expected to be 25–125 bp.
Hybridization using a GeneChip® Hybridization Oven 645
(Affymetrix) was followed by washing using the GeneChip®
Fluidics Station 450 (Affymetrix) and scanning using the
GeneChip®Scanner 3000 7G (Affymetrix).
The raw data obtained were then analyzed by Chromosome
Analysis Suite 2.0 (CHAS2.0) software (Affymetrix) to
figure out the genome-wide CNV and LOH pattern based
on the Hidden Markov Model. The parameter setting was:
CNV size from 50 kb to 3 Mb, marker count >50 and
LOH >100 kb.
Statistical analysis
All data are represented as mean ± s.d. The statistical
significance of differences was determined by Student’s
t-Test. A P value of <0.05 was considered to be statisti-
cally significant.
Results
Derivation and characterization of hESC lines
Previously we have developed a protocol to derive normal
hESC lines from poor-quality embryos [20]. For the present
study, our laboratory received a total of 105 poor-quality
embryos cultured in a modified medium. Blastocysts
formed at day 8 to day 10 (Figure 1B). Then, 21 ICMs
were isolated from the blastocysts and plated onto feeder
layers, 14 of them attached, and finally 9 cell lines grew
out with a typical hESC morphology (Figure 1C). All cell
lines expressed hESC markers such as SSEA-3, SSEA-4
and TRA-1-60 (Figure 1E-G). Each cell line was able to
form embryonic bodies (EBs) (Figure 1D) and expressed
a-fetoprotein (AFP, an endoderm marker), nestin (an ecto-
derm marker) and smooth muscle actin (SMA, a meso-
derm marker) (Figure 1H-J). Teratomas were observedat 4–10 weeks after inoculation into SCID mice. Histo-
logical examination revealed that the teratomas contained
the tissues of the three embryonic germ layers, includ-
ing neural tube-like cells (ectoderm), fat cells (mesoderm)
and glandular tissue (endoderm) (Figure 1K-M). After
characterization of the 9 hES cell lines, we named the 8
hESC lines with the normal karyotype of 46, XX as hES-
20, hES-25, hES-26, hES-27, hES-33, hES-34, hES-35 and
hES-39 (Figure 1N); the cell line hES-12 had a normal
karyotype of 46, XY (Figure 1O).
Heterozygosity of HUMARA gene in hESC lines
To investigate random and skewed XCI patterns, only
heterozygotes can be used to distinguish the maternal
and paternal alleles based on polymorphism of the trinu-
cleotide repeat element at the HUMARA locus [22].
Therefore, we harvested the 8 female hESC lines and the
male hES-12 line, serving as a reference for ‘homozygote’,
at passage 8 to 10 and extracted DNA to analyze the poly-
morphism patterns of the HUMARA gene. 6 out of the 9
investigated cell lines were heterozygous at the HUMARA
locus: hES-20 P9, hES-25 P8, hES-26 P9, hES-27 P10,
hES-35 P9 and hES-39 P10 (Figure 2A-F). 3 cell lines were
homozygous at the HUMARA locus: hES-12 P8, hES-33
P8 and hES-34 P9 (Figure 2G-I). Therefore, the 6 hetero-
zygous cell lines were further analyzed for random or
skewed XCI patterns.
Different XCI patterns in hESC lines
At early undifferentiated passages, all of the 6 hESC lines
had both active and inactive X chromosome alleles. In
XCI pattern assays, 3 lines (hES-25 P8, hES-26 P9 and
hES-35 P9) had a random XCI pattern, possessing two ac-
tive and two inactive alleles. The peak area ratios between
the two active or inactive alleles were almost 50:50, 64:36
and 60:40 respectively (Figure 3A). The other 3 cell lines
(hES-20 P9, hES-27 P10 and hES-39 P10) had extremely
skewed XCI patterns (only one active and one inactive al-
lele): only the 191 bp active allele and the 215 bp inactive
allele were in hES-20 P12; only the 216 bp active allele
and the 198 bp inactive alleles were in hES-27 P10; only
the 199 bp active allele and the 190 bp inactive alleles
were in hES-39 P10 (Figure 3B). Blood DNA from a nor-
mal female who had a random XCI pattern was used as a
positive control (Figure 3C), and blood DNA from a nor-
mal male who had one active X chromosome and lacked
an inactive X chromosome was used as a negative control
(Figure 3D). Thus, we have classified 3 cell lines showing
random XCI pattern and 3 others showing skewed XCI
pattern for further CMA.
CNV status in hESCs
Genome-wide CNVs were identified with a size range from
50 kb to 3 Mb in the random XCI hESC group (hES-25
Figure 1 (See legend on next page.)
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Figure 1 Derivation and characterization of hESC lines. (A) Schematic diagram to present the procedure to establish a hESC model from
poor-quality embryos for study of skewed XCI. The numbers in brackets indicate the number of cell lines in each group. (B) Representative
poor-quality embryo culture in modified medium. (C) Colony morphology under an inverted microscope. (D) EB formation at day 7 when
plated in suspension dishes. (E-G) Immunostaining analysis of hESCs for anti-SSEA-3 (green), anti-SSEA-4 (green) and anti-TRA-1-60 (green).
(H-J) Immunostaining analysis for in vitro differentiation into cell types representative of the three embryonic germ layers, including
alpha-fetoprotein (AFP, endoderm), nestin (ectoderm) and smooth muscle actin (SMA, mesoderm). (K-M) Histological examination of in vivo
differentiation showing that the teratomas contained tissues of the three embryonic germ layers, including neural-tube like cells (ectoderm), fat cells
(mesoderm) and glandular tissue (endoderm). (N, O) Normal karyotypes of 46, XX and 46, XY. Bars in (B-M): 100 μm.
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group (hES-20 P9, hES-27 P10 and hES-39 P10) by Affy-
metrix CytoScan 750 K Arrays (Figure 4A,C). Both groups
showed higher CN losses than CN gains and enriched
CNVs on the X chromosome (Figure 4B,D). However,
there were more CNVs in the skewed group than in the
random group. In the random group, the average total per-
cent of CNVs in the genome by size was 0.13%; while in
the skewed group, it was 0.38%. Particularly, the average
percentage of CNVs in the X chromosome by size was
1.03% in the random group, but it was up to 2.88% in the
skewed group, which was twice higher than that of the
random group (Figure 4B,D). These results indicated that
the skewed group had a high genomic instability, espe-
cially in the X chromosome, than the random group.
LOH analysis in hESCs
LOH was identified with a size larger than 100 kb. In both
random and skewed groups, LOH was mainly associatedFigure 2 Heterozygosity of the HUMARA gene in hESC lines. The poly
(A-F) 6 cell lines have two different HUMARA alleles, indicating that they a
hES-35 and hES-39; (G-I) the other 3 cell lines have only one HUMARA alle
hES-33 and hES-34. X-axis indicates the size (bp) of DNA product.with the X chromosome (Figure 5A,B) and large regions
of LOH (all were larger than 3 Mb) were commonly found
at the 5’ upstream of the XIST locus at Xq13.2 and the
XACT locus at Xq23 (Figure 5C). The difference was, in
the skewed XCI group, the LOH regions of hES-20 and
hES-27 covered the XIST locus and in hES-39, the LOH
region included the XACT locus (Figure 5C). XIST is a
master effector of the inactive X chromosome and XACT
is a newly discovered long non-coding RNA that coats the
active X chromosome specifically in human pluripotent
stem cells. Hence, the LOHs in these loci might correlate
with the skewed XCI pattern.
Discussion
X-chromosome inactivation (XCI) results in the silencing
of most genes on one X chromosome, yielding mono-
allelic expression in individual female cells; while random
XCI results in the expression of both alleles in most fe-
males [13]. In female embryos, XCI is present as early asmorphism patterns of the HUMARA gene in the hESC lines show that
re heterozygous at the HUMARA locus: hES-20, hES-25, hES-26, hES-27,
le, indicating that they are homozygous at the HUMARA locus: hES-12,
Figure 3 Different XCI patterns in heterozygous hESC lines. (A) shows random XCI in hES-25, hES-26 and hES-35 where two active and two
inactive alleles of the HUMARA gene are detected. The peak area ratios between the two active or inactive alleles are 50:50, 64:36 and 60:40
respectively. (B) shows skewed XCI of hES-20, hES-27 and hES-39 where only one active allele and another different inactive allele of the
HUMARA gene are detected. (C) shows normal female blood DNA as a control for random XCI (two active and two inactive alleles, 183
and 200 bp, respectively), and (D) shows normal male blood DNA with only a 190 bp active allele and no inactive allele detected. X-axis
indicates the size (bp) of DNA product.
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at intermediate passages, the XCI state is variable: Class I
hESCs are at pre-XCI state with two active X chromosome,
and initiate XCI upon differentiation; Class II hESCs are
at post-XCI state with one inactive X chromosome; Class
III hESCs also retain an inactive X chromosome despiteabsence of XCI markers [24]. Class II hESCs are found in
most cases [24]. Dvash et al. found that hESC lines at early
passages already exhibit various XCI states, including the
skewed XCI pattern, and suggested that it might reflect
innate heterogeneity of the original cells found in the ICM
of the human embryo [12]. Hence, the generation of
Figure 4 CNV status in hESC lines. (A) The genome-wide CNV status of the random XCI hESC group (hES-25 P8, hES-26 P9 and hES-35 P9).
(B) Average chromosomal distribution of 50 kb-3 MB size CNVs in the random XCI hESC group. (C) The genome-wide CNV status of the skewed
XCI hESC group (hES-20 P9, hES-27 P10 and hES-39 P10). (D) Average chromosomal distribution of 50 kb-3 MB size CNVs in the skewed XCI hESC
group. Blue marks indicate regions of copy number gains. Red marks indicate regions of copy number loss. Only CNVs with a size from 50 kb to 3 Mb
are counted. RXCI, random X chromosome inactivation. SXCI, skewed X chromosome inactivation. Error bars represent SD. *P <0.05 versus RSCI group.
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mechanism of XCI initiation during embryogenesis. In the
present study, we isolated the ICM from poor-quality em-
bryos and established 8 female hESC lines used as a model
system to understand XCI initiation and maintenance. All
of the hESC lines exhibited pluripotent gene expression,
normal chromosome G-banding and teratoma formation
in vivo.
The data available thus far on XCI patterns in hESCs
are diverse. Different XCI patterns in undifferentiated
female hESCs have been reported in different cell lines
[25,26]. To examine XCI skewing, the presence of a poly-
morphism was required to distinguish the two X chromo-
somes and to determine which X chromosome is inactive
[22]. Therefore, we initially analyzed the heterozygosity
of the X-linked HUMARA gene. Because hESCs are de-
rived from human fertilized oocytes, the heterozygosity
between adult females and female hESC lines should be
the same [27]. Our data showed that 75% (6 out of 8)
female hESCs lines were heterozygous at the HUMARA
locus, which is a similar rate to adult females [27]. Therefore,
only 6 heterozygous cell lines were further analyzed for
random or skewed XCI patterns.Although the hESC lines were cultured under the same
condition, both random and skewed XCI patterns could
be found in them [21]. In our study, we harvested hESC
lines from passage 8 to 10 for XCI pattern assays. If ran-
dom XCI occurs in hESCs, there should be two active al-
leles and two inactive alleles, and the peak area ratio of
both the active and inactive alleles should be between
50:50 to 80:20 [21]. Skewed XCI is arbitrarily defined as
more than 80% of cells showing a preferential inactivation
of the same X chromosome [28]. Our data demonstrated
that 3 lines (hES-25 P8, hES-26 P9 and hES-35 P9) had a
random XCI pattern, possessing two active and two in-
active alleles. The peak area ratios between the two active
or inactive alleles were almost 50:50, 64:36 and 60:40.
Meanwhile, the other 3 lines (hES-20 P9, hES-27 P10 and
hES-39 P10) exhibited extremely skewed XCI patterns
(only one active and one inactive allele). Therefore, we
propose that culture condition may not be a key influen-
cing factor for adaptive selection of skewed XCI.
CMA is an emerging high-throughput technique to pro-
file the genome-wide CNV and LOH patterns in hESC
lines. Our Affymetrix CytoScan 750 K Array data showed
that the CNV patterns were different between the skewed
Figure 5 LOH status in hESC lines. (A) The genome-wide LOH status of the random XCI hESC group. (B) The genome-wide LOH status of the
skewed XCI hESC group. (C) Enlarged diagram showing the LOH status around the XIST locus and the XACT locus. Purple bars indicate regions of
LOH. Only LOHs with a size larger than 100 kb are counted.
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group, the average percent of CN gain by size was 0.14%
of the whole genome and 0.07% of the X chromosome;
the average CN loss was 0.14% of the whole genome and
2.81% of the X chromosome. In the random group, the
average percent of CN gain by size was 0.04% of the whole
genome and 0.08% of the X chromosome; the average
CN loss was 0.08% of the whole genome and 0.95% of
the X chromosome. In both groups, CN losses were more
than gains; meanwhile, more CNVs were found on the
X chromosome. These data revealed that the skewed
group had higher X chromosome instability than the ran-
dom group.
XIST is a noteworthy non-coding transcript in that,
in addition to silencing an entire chromosome, it is the
only lncRNA described thus far to widely coat the chromo-
some from which it is expressed [8]. This coating induces
nuclear reorganization and recruitment of histone-
modifying complexes that are important for the initiation
and maintenance of XCI [29]. The XACT gene is located
on chromosome Xq23 between the protein-coding genes
AMOT and HTR2C in an unusually large intergenic re-
gion [8]. It was the first lncRNA identified to coat the
active X chromosome specifically in human pluripotent
stem cells. XACT might not be conserved in mice, and
its function might be related to the specific kinetics
of XCI that were recently described in humans [8].
Vallot et al. speculate that XACT is one of the rapidly
evolving lncRNAs that involve in the species-specific
regulation of XCI initiation in human, just like Tsix in
mice [8]. In our study comparing the skewed XCI hESC
group and random group, LOH was mainly associated
with the X chromosome. In the skewed group, the LOHs
covered the XIST locus at Xq13 in hES-20 and hES-27
and the XACT locus at Xq23 in hES-39, which was not
found in the random group. We speculate that LOH
in either XIST or XACT locus is a factor that impacts
skewed XCI pattern.
Conclusion
In conclusion, the data presented here highlight the di-
verse XCI status in early-passage hESCs and, most im-
portantly, increased instability on X chromosome and
LOHs covering either XIST or XACT gene locus in
hESCs with skewed XCI. More in-depth work is needed
to characterize the association between X chromosome
instability and skewed XCI in these cells.Additional files
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